Package 55700-849-30

Brand: BUPROPION HYDROCHLORIDE

Generic: BUPROPION HYDROCHLORIDE
NDC Package

Package Facts

Identity

Package NDC 55700-849-30
Digits Only 5570084930
Product NDC 55700-849
Product ID 55700-849_bbb443b1-e9c5-4dd5-ade3-365f1faa2151
Description

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (55700-849-30)

Marketing

Marketing Status
Discontinued 2026-02-28
Brand BUPROPION HYDROCHLORIDE
Generic BUPROPION HYDROCHLORIDE
Sample Package No

Linked Drug Pages (1)

BUPROPION HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "bbb443b1-e9c5-4dd5-ade3-365f1faa2151", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["5301bc62-888a-4151-8938-d61f0e52bb45"], "manufacturer_name": ["Quality Care Products, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (55700-849-30)", "package_ndc": "55700-849-30", "marketing_end_date": "20260228", "marketing_start_date": "20200316"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "55700-849_bbb443b1-e9c5-4dd5-ade3-365f1faa2151", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "55700-849", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Quality Care Products, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA210497", "marketing_category": "ANDA", "marketing_end_date": "20260228", "marketing_start_date": "20200316"}